Elixinol Global Ltd (EXL) has continued strong revenue growth across all sales channels which include direct to consumer, wholesale, private label and bulk sales led by broader consumer awareness and demand for hemp-derived CBD products. For its FY2018, EXL posted revenue of $37.1m, increased 121% year-over-year. As at 31 December 2018, EXL has a strong net cash position of $42.7m ($42.9m cash and $0.25m in debt)
http://crweworld.com/article/news-provided-by-globenewswire/995999/elixinol-global-limited-fy2018-results-strong-revenue-growth-of-121-supported-by-robust-balance-sheet-to-drive-future-growth-
Ann: FY 2018 Results ASX Announcement, page-2
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.605M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.605K | 321.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 6265944 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 14532474 | 10 |
View Market Depth
| Last trade - 15.57pm 25/11/2024 (20 minute delay) ? |
| EXL (ASX) Chart |
